Page last updated: 2024-10-26

valproic acid and Friedreich Disease

valproic acid has been researched along with Friedreich Disease in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"A 29-year-old female patient with Friedreich's ataxia and partial seizures with acute liver failure during VPA treatment is reported."1.30Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. ( Hehlmann, R; Heubner, C; Holm, E; König, I; König, SA; Schenk, M; Sick, C; Weiss, A, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herman, D1
Jenssen, K1
Burnett, R1
Soragni, E1
Perlman, SL1
Gottesfeld, JM1
König, SA1
Schenk, M1
Sick, C1
Holm, E1
Heubner, C1
Weiss, A1
König, I1
Hehlmann, R1

Other Studies

2 other studies available for valproic acid and Friedreich Disease

ArticleYear
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia.
    Nature chemical biology, 2006, Volume: 2, Issue:10

    Topics: Acetylation; Alleles; Anilides; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme

2006
Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults.
    Epilepsia, 1999, Volume: 40, Issue:7

    Topics: Adolescent; Adult; Chemical and Drug Induced Liver Injury; Comorbidity; Epilepsy; Fatal Outcome; Fem

1999